Form D · Biotechnology
ORGANOVO HOLDINGS, INC.
San Diego, CA · CIK 0001497253
Offering snapshot reported Jan 4, 2013 · SEC filing
- Reported sold
- $7.66M Offering amount: $7.66M
- Investors reported
- 109 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 21, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 4, 2013 | Initial | $7,662,675 | No comparison | 109 | SEC filing |
| Feb 29, 2012 | Amendment | $8,331,977 | No comparison | 119 | SEC filing |
| Feb 7, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 4, 2010 | Initial | $178,250 | No comparison | 34 | SEC filing |
Offering details
- Securities
- Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $173K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-189455
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Aegis Capital Corp. | 15007 |
Source: Form D, filed Jan 4, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert, Jr. Baltera | Director |
| Robert, Jr. Baltera | Director |
| Robert Baltera, Jr. | Director |
| James Coker | Director, Executive |
| Eric Michael David | Executive |
| Andras Forgacs | Director |
| James T. Glover | Director |
| James T. Glover | Director |
| Deborah Lovig | Director, Executive |
| Barry Michaels | Executive |
| Keith Murphy | Director, Executive |
| Sharon Collins Presnell | Executive |
| Michael Renard | Executive |
| Adam K. Stern | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6275 Nancy Ridge Drive Suite 110
San Diego, CA, 92121
San Diego, CA, 92121